2004

Feb 17, 2004
Guidant Increases Quarterly Dividend

Company Announces Share Repurchase Program INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s...

Jan 29, 2004
Guidant Reports Record Fourth Quarter Sales of $951 million, 8 Percent Sales Growth; Record Full-Year 2003 Sales of $3.7 billion, 17 Percent Sales Growth

Fourth quarter highlights: Worldwide implantable defibrillator revenue of $396 million, up 30 percent Worldwide stent revenue of $202 million, down 17 percent; up 2 percent versus third quarter...

Jan 29, 2004
Guidant Announces U.S. Launch of Cardiac Resynchronization Therapy Pacemaker

Guidant Receives FDA Approval Based on COMPANION Clinical Trial Data Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Jan 28, 2004
Guidant to Participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Jan 22, 2004
Guidant Announces Agreement to Acquire Surgical Cardiac Ablation Company

Acquisition Positions Guidant to Enter New Therapy Area Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Show 5102550100 per page
Top